ARTICLE | Company News
Maxygen, DSM Anti-Infectives deal
March 8, 1999 8:00 AM UTC
The companies will collaborate for three years to generate novel enzymes involved in the manufacture of certain classes of antibiotics using Maxygen's DNA Shuffling or Molecular Breeding technologies....